Hi, what are you looking for?
Jewish Business News
Search results for "Protalix"
Business
– Smallcap investor network report: An experimental Ebola drug can be produced on Protalix‘s vegetable platform. Anxiety about the Ebola disease increased again at...
VC, Investments
Shares of the Israeli biotech firm Protalix went on a bumpy up and down ride on Sunday due to the misunderstanding that a report...
Business
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
Business
– Sales of Protalix’s Gaucher’s disease drug to Pfizer totaled $4.4 million in 2013. – – Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) is not yet seeing...
Money
– The Gaucher and plant-cell treatment developer is offering a convertible note to US financial institutions. – -/ By Nadav Neuman /...
Business
– – / By Alan Gallindoss / Protalix BioTherapeutics announced today, June 19th, 2013, that it has entered into a supply and technology transfer...
Business
Valens, an Israeli startup that provides high-speed connectivity solutions – chips — for the audio-video and automotive markets, is one of a number of...
Blogs
Today I present to you my predictions for Israel’s medical achievements that will take place in the forthcoming new Jewish Year of 5776. They...
Business
As Israel’s biggest company Teva strives to get even bigger by swallowing up rival Mylan for more than $40 billion, further down the food...
Blogs
In the 25th Jan 2015 edition of Israel’s good news, the highlights include: · Johnson & Johnson and Takeda have started...